Australia's largest stock trading and investment forum Australia's #1 stock forum

ACTINOGEN MEDICAL LIMITED

4.00%

2.4¢

Market Cap $76.25M

Healthcare Biotechnology

Actinogen Medical (ACW) is an ASX-listed, biotechnology company developing a novel... Actinogen Medical (ACW) is an ASX-listed, biotechnology company developing a novel therapy for neurological diseases associated with dysregulated brain cortisol. There is a strong association between cortisol and detrimental changes in the brain, affecting cognitive function, harm to brain cells and long term cognitive health.More

Corporate Spotlight

Actinogen is a neurotherapeutics developer realizing a revolutionary therapy so neurology patients and their families can live their best lives.
View the full Corporate Spotlight

Actinogen reaches 100th participant milestone

Latest Threads

Tag

Subject

Ann: Notification of buy-back - ACW

30/07/25

3

948

30/07/25

Last post Stealth101

3

948

Ann: Actinogen June 2025 quarterly activity report & Appendix 4C

30/07/25

1

524

30/07/25

Last post butcherano

1

524

Ann: ACW presents key clinical data at AAIC dementia meeting

28/07/25

2

965

28/07/25

Last post stormer

2

965

2025 will be the year

3 4 5

25/07/25

282

113K

25/07/25

Last post stormer

282

113K

ACW , exciting 6 months ahead !

23/07/25

9

3.2K

23/07/25

Last post stormer

9

3.2K

Ann: ACW 100th AD trial participant & interim analysis timeline

18/07/25

23

11K

18/07/25

Last post jellyroll

23

11K

Ann: ACW accesses up to $13.8m in non-dilutive R&D tax funding

02/07/25

12

4.0K

02/07/25

Last post Lait

12

4.0K

With 100 enrolled and $13.8M in hand, Actinogen's Xanamem timeline is in full swing

30/06/25

1

669

30/06/25

Last post Jakjazz

1

669

Misspelly

25/06/25

1

838

25/06/25

Last post Misspelly

1

838

Ann: ACW presents at BIO international partnering conference

22/06/25

32

10K

22/06/25

Last post jellyroll

32

10K

Calm and Objective

13/06/25

53

18K

13/06/25

Last post stormer

53

18K

Estimating Actinogen's potential value - per Grok

11/06/25

3

1.6K

11/06/25

Last post stormer

3

1.6K

Ann: ACW Science Forum today - Preparing for commercialization

2

26/05/25

74

26K

26/05/25

Last post Stealth101

74

26K

Ann: Ceasing to be a substantial holder

21/05/25

0

669

21/05/25

Last post

ASX News

0

669

Ann: Actinogen CMO presents positive depression data at APA 2025

20/05/25

5

2.3K

20/05/25

Last post stormer

5

2.3K

Ann: Actinogen March 2025 quarterly activity report & Appendix 4C

04/05/25

19

8.0K

04/05/25

Last post Stealth101

19

8.0K

See All Discussions

Corporate Spotlight

ABOUT US

Timeline

Actinogen June 2025 quarterly activity report & Appendix 4C
30 Jul 08:55	Share

Notification of buy-back - ACW
30 Jul 08:31	Share

ACW presents key clinical data at AAIC dementia meeting
28 Jul 09:46	Share

ACW accesses up to $13.8m in non-dilutive R&D tax funding
30 Jun 09:11	Share

ACW 100th AD trial participant & interim analysis timeline
30 Jun 08:57	Share

ACW presents at BIO international partnering conference
16 Jun 09:00	Share

Ceasing to be a substantial holder
21 May 08:21	Share

Actinogen CMO presents positive depression data at APA 2025
19 May 11:04	Share

ACW Science Forum today - Preparing for commercialization
15 May 09:21	Share

Actinogen March 2025 quarterly activity report & Appendix 4C
30 Apr 09:05	Share

ACW Science Forum notice - Preparing for commercialization
24 Apr 08:28	Share

Change in substantial holding
23 Apr 11:18	Share

ACW CMO presents Xanamem pTau poster at ADPD25 conference
02 Apr 12:28	Share

ACW conducts Type C meeting with FDA regarding depression
27 Mar 11:58	Share

Actinogen presentation to ASX small & mid-caps conference
26 Mar 11:06	Share

Appendix 3Ys x 5
24 Mar 16:58	Share

Notification of cessation of securities - ACW
24 Mar 16:44	Share

Notification of cessation of securities - ACW
24 Mar 16:44	Share

Application for quotation of securities - ACW
24 Mar 16:42	Share

Results of Meeting
14 Mar 10:35	Share

Notification of buy-back - ACW
04 Mar 16:56	Share

ACW HY25 results Advancing to latestage clinical development
24 Feb 15:28	Share

Actinogen HY2025 financial report and Appendix 4D
24 Feb 15:27	Share

Letter to Shareholders, Notice of GM & Proxy Form
10 Feb 13:28	Share

Peer-reviewed clinpharm manuscript published
06 Feb 13:34	Share

Application for quotation of securities - ACW
30 Jan 14:04	Share

ACW December 2024 quarterly activity report & Appendix 4C
29 Jan 08:58	Share

ACW presents at Sachs Neuro & WHO grants INN emestedastat
13 Jan 09:14	Share

Change in substantial holding
19 Dec 08:16	Share

Application for quotation of securities - ACW
16 Dec 17:04	Share

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 2.4¢		Change -0.001(4.00%)		Mkt cap ! $76.25M

Open	High	Low	Value	Volume
2.4¢	2.5¢	2.4¢	$28.67K	1.192M

Buyers (Bids)

No.	Vol.	Price($)
17	3607729	2.4¢

Sellers (Offers)

Price($)	Vol.	No.
2.5¢	1004306	3

View Market Depth

No.	Vol.	Price($)
17	3607729	0.024
10	2560042	0.023
11	1851493	0.022
8	4451720	0.021
15	5059980	0.020

Price($)	Vol.	No.
0.025	1004306	3
0.026	593253	9
0.027	791815	6
0.028	680042	6
0.029	1233142	3

Last trade - 16.10pm 31/07/2025 (20 minute delay)


Last 2.4¢			Change -0.001 ( 4.00 %)
Open	High		Low	Volume
2.5¢	2.5¢		2.4¢	365677
Last updated 15.59pm 31/07/2025 ?

ACW (ASX) Chart